Skip to main content
Figure 8 | Arthritis Research & Therapy

Figure 8

From: Infliximab: 12 years of experience

Figure 8

Ankylosing spondylitis: rapid clinical response. Infliximab rapidly improves ASAS40 compared with placebo (n = 279 patients). P <0.001 from 2 weeks onwards. ASAS, Assessment of SpondyloArthritis International Society. Modified with permission from [75].

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us